Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

被引:184
作者
Ribaudo, JM
Cella, D [1 ]
Hahn, EA
Lloyd, SR
Tchekmedyian, NS
Von Roenn, J
Leslie, WT
机构
[1] Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL 60201 USA
[2] Northwestern Univ, Evanston, IL USA
[3] Ctr Conscious Living, Naperville, IL USA
[4] Pacific Shores Med Grp, Long Beach, CA USA
[5] Northwestern Univ, Sch Med, Dept Med, Hematol Oncol Sect, Chicago, IL 60611 USA
[6] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
关键词
anorexia/cachexia; quality of life; scale validation;
D O I
10.1023/A:1016670403148
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The original Functional Assessment of Anorexia/Cachexia Therapy (FAACT) was designed to measure general aspects of quality of life (QOL) as well as specific anorexia/cachexia-related concerns. Our primary purpose was to reduce the number of anorexia/cachexia subscale items in a manner that either retains or improves reliability, validity and precision. Methods: The FAACT was administered using an interactive computer program that allowed immediate entry of the data. A total of 213 patients were recruited. Results: A combined empirical and conceptual approach led to the reduction of the anorexia/cachexia subscale (A/CS) from 18 to 12 items. A 26-item trial outcome index (TOI) combining physical well-being (PWB), functional well-being (FWB), and the A/CS-12 was highly reliable and sensitive to change in performance status rating (PSR). We found that PWB, FWB, and A/CS-12 subscales performed differently. Specifically, PWB and FWB scores decreased in patients whose (PSR) worsened. However, although A/CS-12 scores were responsive to change in PSR over time, average A/CS-12 scores of all patients, even those whose PSR worsened, improved over the course of treatment. Conclusions: Elimination of six items from the anorexia/cachexia subscale of the FAACT was accomplished without loss of internal consistency or sensitivity to change in performance status. The A/CS-12 subscale provides unique, important information not captured by a generic chronic illness questionnaire.
引用
收藏
页码:1137 / 1146
页数:10
相关论文
共 22 条
[1]
ALEXANDER HR, 1994, OXFORD TXB PALLIATIV, P316
[2]
[Anonymous], 1997, MANUAL FUNCTIONAL AS
[3]
[Anonymous], 1993, ONCOLOGY-BASEL
[4]
Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[5]
CALHOUN EA, 2000, 36 ASCO ANN M 20 23
[6]
CELLA D, 1991, ONCOLOGY S NOV
[7]
CELLA D, 1987, J CHRON DIS, V40, P171
[8]
RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY - LUNG (FACT-L) QUALITY-OF-LIFE INSTRUMENT [J].
CELLA, DF ;
BONOMI, AE ;
LLOYD, SR ;
TULSKY, DS ;
KAPLAN, E ;
BONOMI, P .
LUNG CANCER, 1995, 12 (03) :199-220
[9]
THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[10]
THE BRISTOL-MYERS ANOREXIA CACHEXIA RECOVERY INSTRUMENT (BACRI) - A BRIEF ASSESSMENT OF PATIENTS SUBJECTIVE RESPONSE TO TREATMENT FOR ANOREXIA CACHEXIA [J].
CELLA, DF ;
VONROENN, J ;
LLOYD, S ;
BROWDER, HP .
QUALITY OF LIFE RESEARCH, 1995, 4 (03) :221-231